Edmond DE Rothschild Holding S.A. Sells 224 Shares of Agilent Technologies, Inc. (NYSE:A)

Edmond DE Rothschild Holding S.A. lessened its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 0.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 36,902 shares of the medical research company’s stock after selling 224 shares during the quarter. Edmond DE Rothschild Holding S.A.’s holdings in Agilent Technologies were worth $4,957,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in A. Flynn Zito Capital Management LLC lifted its stake in shares of Agilent Technologies by 3.8% in the 4th quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company’s stock valued at $251,000 after purchasing an additional 69 shares during the period. IFP Advisors Inc lifted its position in Agilent Technologies by 17.7% during the fourth quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock valued at $62,000 after buying an additional 69 shares during the period. Tiemann Investment Advisors LLC boosted its holdings in shares of Agilent Technologies by 5.6% during the 4th quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company’s stock valued at $191,000 after buying an additional 75 shares in the last quarter. Rothschild Investment LLC grew its position in shares of Agilent Technologies by 19.2% in the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock worth $66,000 after buying an additional 79 shares during the period. Finally, Ascent Group LLC increased its stake in shares of Agilent Technologies by 4.1% in the 3rd quarter. Ascent Group LLC now owns 2,209 shares of the medical research company’s stock worth $328,000 after acquiring an additional 87 shares in the last quarter.

Wall Street Analysts Forecast Growth

A has been the topic of several research reports. Citigroup boosted their price objective on shares of Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research note on Thursday, December 19th. Bank of America cut their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research note on Friday, December 13th. Robert W. Baird lowered their price objective on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research note on Thursday, February 27th. Wells Fargo & Company cut their target price on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research note on Monday, December 9th. Finally, StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Seven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $150.83.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP Rodney Gonsalves sold 1,908 shares of the firm’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. This trade represents a 8.05 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Stock Up 0.3 %

A opened at $116.99 on Tuesday. Agilent Technologies, Inc. has a twelve month low of $113.76 and a twelve month high of $155.35. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The firm has a 50 day moving average price of $133.68 and a 200-day moving average price of $136.49. The stock has a market capitalization of $33.35 billion, a price-to-earnings ratio of 26.89, a PEG ratio of 3.27 and a beta of 1.11.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. The firm had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.85%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s payout ratio is currently 22.76%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.